Newsroom

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quiver Bioscience wins NIH HEAL grant to advance QV-2421, its Nav1.7 ASO therapy for chronic neuropathic pain, toward human trials....

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--KinderCare Learning Companies, Inc. (NYSE: KLC) (“KinderCare”), the nation’s leading provider of high-quality early childhood education and care, is celebrating Teacher Appreciation Week with a special thank you to K-12 teachers and district staff. KinderCare will offer staff and teachers at any school district that its before- and after-school brand Champions operates in with a tuition benefit of 10% off child care at any KinderCare Learning Center (KCLC). “...

LOUISVILLE, Colo.--(BUSINESS WIRE)--Infleqtion (NYSE: INFQ) (the “Company”), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, today announced that it will release its financial results for the quarter ended March 31, 2026, on Thursday, May 14, 2026, after the financial markets close. The Company will host a conference call at 4:30 PM Eastern Time the same day to discuss financial results. The call will be webcast live on the Company’s Investor Relatio...

PHOENIX--(BUSINESS WIRE)--Pinnacle West reports first-quarter 2026 financial results driven by hotter-than-normal weather....

NEW YORK--(BUSINESS WIRE)--NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, has received a Bronze Stevie® Award for “AI-Driven Success in Action” in the 2026 American Business Awards®, the premier U.S. business awards program. Nominated for the category of “AI in Healthcare Achievement,” NextGen Healthcare was recognized by the judging panel for “showing real improvements in provider productivity, patient access, and operational efficiency” and...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of its clinician-directed telehealth platform under Niagen™ Plus, enabling eligible patients in the U.S. to access prescription-only, pharmaceutical-grade Niagen® (patented nicotinamide riboside chloride, NRCl) from home with the first-of-its-kind Niagen® At-Home Injection Kit. The launch m...

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (Nasdaq: KOPN) (“Kopin” or the “Company”), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced it will release select unaudited financial results for the first quarter ended March 28, 2026 before market open on Tuesday, May 12, 2026. Management will host an investor conference call at 8:30 AM Eastern time o...

COLUMBUS, Ohio--(BUSINESS WIRE)--The O.H.I.O. Fund today reported strong first-quarter momentum, increasing total committed capital to its private funds from $356 million at the end of Q4 2025 to $647 million on March 31, 2026. The O.H.I.O. Fund is a private fund investment adviser seeking to generate strong returns for investors while supporting economic growth in Ohio. The increase was driven by more than $290 million in commitments from 18 new investors in the firm’s evergreen fund. These co...

MIAMI--(BUSINESS WIRE)--A joint venture between Sculptor Real Estate Income Strategy—Sculptor Real Estate’s core plus strategy focused on differentiated, stabilized, income-producing real estate—and Trinity Investments (“Trinity”), a global hospitality-focused investment firm, announced today the acquisition of the JW Marriott Marco Island Beach Resort (the “Property”), a luxury beachfront resort located on Florida’s Gulf Coast, from MassMutual, a leading mutual life insurance company. Situated...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients...